Impaired growth hormone secretion in fibromyalgia patients: Evidence for augmented hypothalamic somatostatin tone
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: To determine whether female fibromyalgia (FM) patients exhibit a normal growth hormone (GH) response to an acute exercise stressor, and to assess the importance of somatostatin tone in the generation of this GH response. Methods: Twenty female FM patients were compared with 10 healthy female controls. All subjects exercised to volitional exhaustion on a treadmill. A standard metabolic cart was used to monitor pulse, blood pressure, electrocardiography, oxygen uptake, carbon dioxide output, anaerobic threshold, and maximal workload. Blood was drawn for GH and cortisol measurements 1 hour before exercise, immediately before exercise, immediately after exercise, and 1 hour after exercise. One month later, testing that was exactly similar was performed, except all subjects were given pyridostigmine bromide (Mestinon; 30 mg orally) 1 hour before exercise. Results: Compared with controls, FM patients failed to exhibit a GH or cortisol response to acute exercise (P = 0.003). After administration of pyridostigmine, 1 hour before exercise, the GH levels of FM patients increased 8‐fold (P = 0.001), to a value comparable with that of controls. Pyridostigmine did not increase the cortisol response to exercise in FM patients. Pyridostigmine alone did not stimulate GH secretion in FM patients, nor did it improve exercise‐induced GH secretion in controls. FM patients with normal insulin‐like growth factor 1 (IGF‐1) levels had an impaired GH response to exercise. Conclusion: Three new findings are reported: 1) FM patients have a reduced GH response to exercise, 2) pyridostigmine reverses this impaired response, and 3) defective GH secretion in FM can occur in patients with normal IGF‐1 levels. Because pyridostigmine is known to reduce somatostatin tone, it is surmised that the defective GH response to exercise in FM patients probably results from increased levels of somatostatin, a hypothalamic hormone that inhibits GH secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heim, C., Ehlert, U., Hanker, J. P., & Hellhammer, D. H. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199805000-00017 · Cited by 309 · cited 1×
“There are several examples of human stressrelated disorders other than FM in which patients exhibit evidence of impaired cortisol secretion: chronic pelvic pain syndrome (48), chronic fatigue syndrome (CFS) (49), posttraumatic stress disorder (50), and overtraining syndrome (51).”
BackgroundNew approach to the diagnosis of growth hormone deficiency in adults
Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E., & Camanni, F. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340352 · Cited by 257
Hormonal pertubations in fibromyalgia syndrome
NEECK, G., & RIEDEL, W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07657.x · Cited by 43 · cited 1×
“For instance, Neeck and Riedel hypothesized that a stress-induced increase in CRF is the common denominator linking the disturbed HPA axis and reduced GH secretion in FM (36), the critical link being the observation that CRF increases hypothalamic somatostatin tone (44,45).”
Background
Cited by
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
Staud, R., Robinson, M. E., & Price, D. D. (2005) · Pain · doi:10.1016/j.pain.2005.08.007 · Cited by 266
Tak, L. M., Cleare, A. J., Ormel, J., Manoharan, A., Kok, I. C., Wessely, S., & Rosmalen, J. G. M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.02.002 · Cited by 230
Menopause Related Sleep Disorders
Eichling, P. S., & Sahni, J. (2005) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26347 · Cited by 178
Fibromyalgia and obesity: the hidden link
Ursini, F., Naty, S., & Grembiale, R. D. (2011) · Rheumatology International · doi:10.1007/s00296-011-1885-z · Cited by 155
“These abnormalities in somatotropic axis seem to be due to an augmented hypothalamic somatostatin tone [59].”
BackgroundMoldofsky, H. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.05.008 · Cited by 59
Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis
Beiner, E., Lucas, V., Reichert, J., Buhai, D.-V., Jesinghaus, M., Vock, S., Drusko, A., Baumeister, D., Eich, W., Friederich, H.-C., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000002857 · Cited by 56
Singh, L., Kaur, A., Bhatti, M. S., & Bhatti, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02805-5 · Cited by 55
Valverde-Filho, J., Cunha Neto, M. B. C. D., Fonoff, E. T., Meirelles, E. D. S., & Teixeira, M. J. (2015) · Pain Medicine · doi:10.1111/pme.12661 · Cited by 37
Lower circulating IGF-1 levels in fibromyalgia: meta-analysis highlighting potential pathogenic role
Lee, Y. H., & Song, G. G. (2024) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/g17lb8 · Cited by 2
Metadata
- Authors
- Paiva, E. S., Deodhar, A., Jones, K. D., & Bennett, R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-05
- Volume
- 46
- Issue
- 5
- Pages
- 1344-1350
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2044980379
- Cited by
- 98
- References
- 3
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.